The effect of ST2 gene product on anchorage-independent growth of a glioblastoma cell line, T98G

European Journal of Biochemistry

Volumn 270, Issue 1, 2003, Pages 163-170

  Haga, Yasushi ^a   Yanagisawa, Ken ^a   Ohto Ozaki, Hiromi ^a   Tominaga, Shin Ichi ^a   Masuzawa, Toshio ^a   Iwahana, Hiroyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Anchorage independent growth; Glioblastoma; IL 1 receptor family; Malignancy; ST2

Indexed keywords

AGAR; GENE PRODUCT; PROTEIN ST2; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BENIGN TUMOR; BRAIN CANCER; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN SECRETION; SAMPLING; TISSUE CULTURE; TISSUE SLICE; TUMOR CELL LINE; TUMOR GROWTH;

BRAIN NEOPLASMS; CELL DIVISION; CENTRAL NERVOUS SYSTEM NEOPLASMS; GLIOBLASTOMA; HUMANS; MEMBRANE PROTEINS; PROMOTER REGIONS (GENETICS); RECEPTORS, CELL SURFACE; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0037219692     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2003.03377.x     Document Type: Article

References (31)

1. Tominaga, S. (1988) Murine mRNA for the β-subunit of integrin is increased in BALB/c-3T3 cells entering the G1 phase from the Go state. FEBS Lett. 238, 315-319.
2. Tominaga, S. (1989) A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett. 258, 301-304.
3. Werenskiold, A.K., Hoffman, S. & Klemenz, R. (1989) Induction of a mitogen-responsive gene after the expression of the Ha-ras oncogene in NIH3T3 fibroblasts. Mol. Cell Biol. 9, 5207-5214.
4. Klemenz, R., Hoffmann, S. & Werenskiold, A.K. (1989) Serum and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen. Proc. Natl Acad. Sci. USA 86, 5708-5712.
5. Bergers, G., Reikerstorfer, A., Braselmann, S., Graninger, P. & Busslinger, M. (1994) Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J. 13, 1176-1188.
6. Lanahan, A., Williams, J.B., Sanders, L.K. & Nathans, D. (1992) Growth factor-induced delayed early response gene. Mol. Cell. Biol. 12, 3919-3929.
7. Yanagisawa, K., Takagi, T., Tsukamoto, T., Tetsuka, T. & Tominaga, S. (1993) Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett. 318, 83-87.
8. Tominaga, S., Kuroiwa, K., Tago, K., Iwahana, H., Yanagisawa, K. & Komatsu, N. (1999) Presence and expression of a novel variant form of ST2 gene product in human leukemic cell line UT-7/GM. Biochem. Biophys. Res. Commun. 264, 14-18.
9. Li, H., Tago, K., Io, K., Kuroiwa, K., Arai, T., Iwahana, H., Tominaga, S. & Yanagisawa, K. (2000) The cloning and nucleotide sequence of human ST2L cDNA. Genomics 67, 284-290.
10. Iwahana, H., Yanagisawa, K., Ito-Kosaka, A., Kuroiwa, K., Tago, K., Komatsu, N., Katashima, R., Itakura, M. & Tominaga, S. (1999) Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. Eur. J. Biochem. 264, 397-406.
11. Yanagisawa, K., Naito, Y., Kuroiwa, K., Arai, T., Furukawa, Y., Tomizuka, H., Miura, Y., Kasahara, T., Tetsuka, T. & Tominaga, S. (1997) The expression of ST2 gene in helper T cells and the binding of ST2 protein to myeloma-derived RPMI8226 cells. J. Biochem. 121, 95-103.
12. Xu, D., Chan, W.L., Leung, B.P., Huang, F.P., Wheeler, R., Pierdrafita, D., Robinson, J.H. & Liew, F.Y. (1998) Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J. Exp. Med. 187, 787-795.
13. Löhning, M., Stroemann, A., Coyle, A.J., Grogan, J.L., Lin, S., Gutierrez-Ramos, J.-C., Levinson, D., Radbruch, A. & Kamradt, T. (1998) T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc. Natl Acad. Sci. USA 95, 6930-6935.
14. Kuroiwa, K., Li, H., Tago, K., Iwahana, H., Yanagisawa, K., Komatsu, N., Oshikawa, K., Sugiyama, Y., Arai, T. & Tominaga, S. (2000) Construction of ELISA system to quantify human ST2 protein in sera of patients. Hybridoma 19, 151-159.
15. Oshikawa, K., Kuroiwa, K., Tago, K., Iwahana, H., Yanagisawa, K., Ohno, S., Tominaga, S. & Sugiyama, Y. (2001) Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am. J. Respir. Crit. Care Med. 164, 277-281.
16. Kuroiwa, K., Arai, T., Okazaki, H., Minota, S. & Tominaga, S. (2001) Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem. Biophys. Res. Commun. 284, 1104-1108.
17. Tominaga, S., Yokota, T., Yanagisawa, K., Tsukamoto, T., Takagi, T. & Tetsuka, T. (1992) Nucleotide sequence of a complementary DNA for human ST2. Biochim. Biophys. Acta 1171, 215-218.
18. Yoshida, K., Arai, T., Yokota, T., Komatsu, N., Miura, Y., Yanagisawa, K., Tetsuka, T. & Tominaga, S. (1995) Studies on natural ST2 gene products in the human leukemic cell line UT-7 using monoclonal antihuman ST2 antibodies. Hybridoma 14, 419-427.
19. Prechtel, D., Harbeck, N., Berger, U., Höfler, H. & Werenskiold, A.K. (2001) Clinical relevance of T1-S, an oncogene-inducible, secreted glycoprotein of the immunoglobulin superfamily, in node-negative breast cancer. Laboratory Invest. 81, 159-165.
20. Oshikawa, K., Yanagisawa, K., Ohno, S., Tominaga, S. & Sugiyama, Y. (2002) Expression of ST2 in helper T lymphocytes of malignant pleural effusions. Am. J. Respir. Crit. Care Med. 165, 1005-1009.
21. Boyle-Walsh, E., Hashim, I.A., Speirs, V., Fraser, W.D. & White, M.C. (1994) Interleukin-6 (IL-6) production and cell growth of cultured human meningiomas: Interactions with interleukin-1β (IL-1β) and interleukin-4 (IL-4) in vitro. Neurosci. Lett. 170, 129-132.
22. Levy, E.I., Paino, J.E., Sarin, P.S., Goldstein, A.L., Caputy, A.J., Wright, D.C. & Sekhar, L.N. (1996) Enzyme-linked immunosorbent assay quantification of cytokine concentration in human meningiomas. Neurosurgery 39, 823-829.
23. Todo, T., Adams, E.F., Rafferty, B., Fahlbusch, R., Dingermann, T. & Werner, H. (1994) Secretion of interleukin-6 by human meningioma cells: Possible autocrine inhibitory regulation of neoplastic cell growth. J. Neurosurg. 81, 394-401.
24. Gottschall, P.E., Koves, K., Mizuno, K., Tatsuno, I. & Arimura, A. (1991) Glucocorticoid upregulation of interleukin 1 receptor expression in a glioblastoma cell line. Am. J. Physiol. 261, 362-368.
25. Gridley, D.S., Loredo, L.N., Slater, J.D., Archambeau, J.O., Bedros, A.A., Andres, M.L. & Slater, J.M. (1998) Pilot evaluation of cytokine levels in patients undergoing radiotherapy for brain tumor. Cancer Detect. Prev. 22, 20-29.
26. Jachimczak, P., Schwulera, U. & Bogdahn, U. (1994) In vitro studies of cytokine-mediated interactions between malignant glioma and autologous peripheral blood mononuclear cells. J. Neurosurg. 81, 579-586.
27. Lichtor, T. & Libermann, T.A. (1994) Coexpression of interleukin-1β and interleukin-6 in human brain tumor. Neurosurgery 34, 669-673.
28. Van Meir, E., Sawamura, Y., Diserens, A.C., Hamou, M.F. & de Tribolet, N. (1990) Human glioblastoma cells release interleukin 6 in vitro and in vivo. Cancer Res. 50, 6683-6688.
29. Giulian, D. & Lachman, L.B. (1985) Interleukin-1 stimulation of astroglial proliferation after brain injury. Science (Wash. DC) 228, 497-499.
30. Giulian, D., Young, D.G., Woodward, J., Brown, D.C. & Lachman, L.B. (1988) Interleukin-1 is an astroglial growth factor in the developing brain. J. Neurosci. 8, 709-714.
31. Sweet, M.J., Leung, B.P., Kang, D., Sogaard, M., Schulz, K., Trajkovic, V., Campbell, C.C., Xu, D. & Liew, F.Y. (2001) A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J. Immunol. 166, 6633-6639.